These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1116361)

  • 1. A comparison of event rates in nulligravid and nulliparous women using the small Dalkon Shield for intrauterine contraception.
    Ostergard DR
    Contraception; 1975 Jan; 11(1):61-8. PubMed ID: 1116361
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrauterine contraception with the copper T-200 and the Dalkon shield in nulligravid women.
    Ostergard DR; Gunning JE
    J Reprod Med; 1976 Sep; 17(3):172-4. PubMed ID: 966243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An association between the Dalkon Shield and complicated pregnancies among women hospitalized for intrauterine contraceptive device--related disorders.
    Kahn HS; Tyler CW
    Am J Obstet Gynecol; 1976 May; 125(1):83-6. PubMed ID: 1275008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum and postabortal insertion of intrauterine contraceptive devices.
    Martorella LA; Esposito JM
    J Reprod Med; 1975 Apr; 14(4):178-81. PubMed ID: 1142352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dalkon shield and the nulliparous patient.
    Crist T; Groce A
    N C Med J; 1973 May; 34(5):369-70. PubMed ID: 4513474
    [No Abstract]   [Full Text] [Related]  

  • 6. The Dalkon Shield in nulliparous women.
    Marshall BR; Hepler JK; Scott RH; Zirbel CC
    Am J Obstet Gynecol; 1974 Jan; 118(2):186-9. PubMed ID: 4809406
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of the Dalkon shield in contraception.
    Ng AY; Chan T; Cheng MC; Hangchi D; Ratnam SS
    Aust N Z J Obstet Gynaecol; 1975 Aug; 15(3):169-72. PubMed ID: 1065308
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrauterine contraception in multiparas with the Dalkon Shield.
    Ostergard DR
    Am J Obstet Gynecol; 1974 Aug; 119(8):1033-7. PubMed ID: 4847440
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term study of the safety of the Dalkon Shield and Gyne-T 200 intrauterine devices.
    Rioux JE; Cloutier D; Dupont P; Lamonde D
    CMAJ; 1986 Apr; 134(7):747-51. PubMed ID: 3948091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.
    Mumford SD; Kessel E
    Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dalkon Shield, the TCu 200, and the TCu 380A in private practice.
    Thomas WO
    Trans Pac Coast Obstet Gynecol Soc; 1977; 44():78-85. PubMed ID: 335580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IUD revisited.
    Fam Plann Perspect; 1975; 7(6):244-7. PubMed ID: 1213079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intrauterine devices in nulliparous women.
    Lohr PA; Lyus R; Prager S
    Contraception; 2017 Jun; 95(6):529-537. PubMed ID: 27591814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate post-abortion insertion of the Dalkon shield.
    Quan A; Edelman DA; Goldsmith A; Thomas M; Zappala-Badia D
    Contraception; 1975 Jul; 12(1):23-9. PubMed ID: 1139946
    [No Abstract]   [Full Text] [Related]  

  • 15. Florida's experience with an intrauterine device for the nulliparous patients.
    Caraway AF
    J Reprod Med; 1975 Sep; 15(3):114-6. PubMed ID: 1214252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine contraception in nulliparas with the Dalkon shield.
    Ostergard DR
    Am J Obstet Gynecol; 1973 Aug; 116(8):1088-91. PubMed ID: 4721137
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of continuation rates of intrauterine devices.
    Measham AR; Villegas A
    Obstet Gynecol; 1976 Sep; 48(3):336-40. PubMed ID: 948377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The experience with Dalkon Shield in UCLA family planning clinic.
    Wang AC
    Nihon Funin Gakkai Zasshi; 1974 Jul; 19(3):12-7. PubMed ID: 4478818
    [No Abstract]   [Full Text] [Related]  

  • 19. [The experience with Dalkon shield in UCLA family planning clinic].
    Wang AC
    Nihon Funin Gakkai Zasshi; 1974 Jul; 19():248-53. PubMed ID: 12158546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.